Last reviewed · How we verify
BROMHEXINE HYDROCHLORIDE
BROMHEXINE HYDROCHLORIDE is a drug. It is currently FDA-approved.
Bromhexine hydrochloride is an intervention studied in clinical trials for various conditions, including Amyotrophic Lateral Sclerosis (ALS), COVID-19, Type I Gaucher Disease, and healthy individuals. It is being tested alongside other interventions, such as Ambroxol and Vitamin C, in a double-blind, randomized, placebo-controlled clinical trial for ALS treatment.
At a glance
| Generic name | BROMHEXINE HYDROCHLORIDE |
|---|---|
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- High-Dose Ambroxol in Pediatric Type III Gaucher Disease (GD3) (NA)
- A Clinical Trial to Compare the Efficacy and Safety of 1-week Treatment of Intravenous N-acetylcysteine (NAC) 600 mg Twice Daily, Ambroxol Hydrochloride 30 mg Twice Daily and Placebo as Expectorant Therapies in Adult Chinese Patients With Respiratory Tract Diseases and Abnormal Mucus Secretions (PHASE3)
- An Open Label Dose Escalation Study to Assess the Safety, Tolerability, and Pharmacologic Properties of High Dose Ambroxol Hydrochloride in Adult (≥ 18 Years of Age) Subjects With MPS III (PHASE2, PHASE3)
- Ambroxol as a Disease-modifying Treatment in GBA-PD (PHASE2)
- Study on the Pharmacokinetics of Bromine Hexane Hydrochloride Tablets in Healthy Adults (PHASE1)
- Ambroxol to Slow Progression in Parkinson Disease (PHASE3)
- A Multicenter, Randomized, Double-Blind, Placebo-Controlled Clinical Study to Evaluate the Safety and Efficacy of Uterine Blood Mesenchymal Stem Cells Injection for the Treatment of Severe Pneumonia Caused by Viruses (PHASE1)
- Ambroxol as a Treatment for Parkinson's Disease Dementia (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- BROMHEXINE HYDROCHLORIDE CI brief — competitive landscape report
- BROMHEXINE HYDROCHLORIDE updates RSS · CI watch RSS
Frequently asked questions about BROMHEXINE HYDROCHLORIDE
What is BROMHEXINE HYDROCHLORIDE?
What development phase is BROMHEXINE HYDROCHLORIDE in?
Related
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing